Delivery Order SPE2DB20D3303-SPE2DB25FA2CP
- Not listed
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order, valued at $1,072.47, is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Telmisartan is an angiotensin II receptor antagonist commonly used in the treatment of hypertension and is a...
- The Defense Logistics Agency awarded a delivery order valued at $4,070.31 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30-count), with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $4,832.84 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Telmisartan 40 mg tablets (30-count packages) valued at $3,788.86. This competitively awarded, firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of August 28, 2025, and represents a continuation of pharmaceutical supply services performed at the vendor's Conshohocken, Pennsylvania location. Telmisartan, an antihypertensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,293.80 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Telmisartan 80 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and is scheduled for ultimate completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,277.46 contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has a period of performance through June 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a delivery order valued at $29,770.38 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) on September 19, 2025, with completion scheduled for September 22, 2025. This delivery order was issued as a firm fixed price contract with no set-aside designation, utilizing open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan 20 mg tablets (quantity 30s) with a firm fixed price ceiling value of $1,223.12. This non-set-aside award was issued on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2CPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,121.12 to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Telmisartan is an antihypertensive medication commonly used in military and veteran healthcare systems to manage high blood pressure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio with DLA and regularly fulfills delivery orders for both brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/4/25 |